Breaking news.
PRIMA Trial. Niraparib v Placebo in ovarian cancer.
Primary endpoint: PFS significant reduction in progression v placebo. Clinical implications... niraparib monotherapy after first line platinum therapy should be new standard of care.
#ESMO2019
Because of routine vaccination, we no longer see smallpox, and polio has almost been eradicated. Find out which vaccinations you and your family are eligible for by using our vaccination checklist: https://t.co/I6dyRCnBUl
Here's nice photo of Beth and Elliott working at the Royal College of Obstetricians and Gynaecologists in London, filming KOLs for a training project. (Aren't you both supposed to be on the other side of the camera? 😊) #medcomms#meded
CREATIVE ARTWORKER.
We are looking for a talented creative to join our vibrant, globally-acclaimed med comms agency. Further your career in digital design and make a positive impact on people’s lives, here: https://t.co/1FNsJUsyfj
#careers#designjobs#html#digital#artwork
Massive congratulations to Jamie on his promotion to Scientific Team Lead. Read more about Jamies's new leadership role and opportunities to join our dynamic agency, here: https://t.co/eUp7Js2taO
#scientificservices#careers#leadership#medcomms#meded
SCIENTIFIC SERVICES DIRECTOR. Porterhouse Medical is looking for a high-level scientific leader to direct our globally-acclaimed team. For details on this outstanding opportunity, visit: https://t.co/NBJ12MxxTx #medcomms#meded#careers
We are thrilled to have been awarded the Investors in People (@IIP) accreditation at the Gold level, demonstrating our commitment to realising the potential of our people.
Read about the IIP, our award and the Porterhouse PATH: https://t.co/iROHKYsG6A #MedComms#MakeWorkBetter